Company news
Shanghai Sanyou Medical Co. Ltd. Class A (SSE:688085) news
Shanghai Sanyou Medical Co. Ltd. Class A news releases on 6ix. Latest, Sep 29, 2026: (688085)"Shanghai Sanyou Medical Co., Ltd."Announcement…
Press releases & updates
(688085)"Shanghai Sanyou Medical Co., Ltd."Announcement on the Satisfaction of Vesting Conditions for the First Vesting Period under the 2025 Restricted Share Incentive Plan
September 28, 2026
(688085)"Shanghai Sanyou Medical Co., Ltd."Announcement on Resolutions of the 14th Meeting of the 4th Board of Directors
September 28, 2026
(688085)"Shanghai Sanyou Medical Co., Ltd."Announcement on Cancellation of Certain Restricted Shares under 2025 Restricted Share Incentive Plan
September 28, 2026
(688085)"Shanghai Sanyou Medical Co., Ltd."Announcement on Adjustment of the Grant Price and Grant Quantity under the 2025 Restricted Share Incentive Plan
September 28, 2026
"Shanghai Sanyou Medical Co., Ltd."Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026
September 28, 2026
"Shanghai Sanyou Medical Co., Ltd."Notice on Convening the 3rd Extraordinary General Meeting in 2026
September 11, 2026
"Shanghai Sanyou Medical Co., Ltd."Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Medical Device and Medical Equipment Industry
September 4, 2026
"Shanghai Sanyou Medical Co., Ltd."Announcement on Repurchase of Shares through Call Auction Reaching 1% and Progress of Share Repurchase
September 1, 2026
"Shanghai Sanyou Medical Co., Ltd."Announcement on Re-appointment of Accounting Firm
August 24, 2026
"Shanghai Sanyou Medical Co., Ltd."Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
August 4, 2026
"Shanghai Sanyou Medical Co., Ltd."Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders of Unrestricted Shares Concerning Share Repurchase
July 24, 2026
"Shanghai Sanyou Medical Co., Ltd."Materials for the 1st Extraordinary General Meeting in 2026
July 22, 2026
"Shanghai Sanyou Medical Co., Ltd."Announcement on Plan of Repurchasing Shares through Call Auction
July 21, 2026
"Shanghai Sanyou Medical Co., Ltd."Voluntary Disclosure Announcement on the Clinical Collaborative Research Conducted by the Controlled Company Implanet and CHU Amiens-Picardie in France, and the Completion of the First Multi-Arm Spinal Surgery Robot Installation in Europe
July 17, 2026
"Shanghai Sanyou Medical Co., Ltd."Notice on Convening the 1st Extraordinary General Meeting in 2026
July 15, 2026
"Shanghai Sanyou Medical Co., Ltd."Indicative Announcement on the Proposal of the Company's Actual Controller to Repurchase the Company's Shares
July 14, 2026
"Shanghai Sanyou Medical Co., Ltd."Announcement on the Company's Waiver of the Preemptive Right to Subscribe for a Capital Increase in an Equity-invested Company and Related Party Transaction
July 1, 2026
Announcement on Cancellation of Some Special Accounts for Raised Funds
June 4, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 21, 2026
Announcement on Attending the 2025 Annual Collective Performance Briefing and Q1 2026 Performance and Cash Dividend Briefing for Medical Device Industry
April 27, 2026
Announcement on Returning Idle Raised Funds Used to Temporarily Supplement Current Capital
April 13, 2026
Announcement on Results of Shareholding Reduction by Actual Controller and Its Person Acting in Concert
March 18, 2026
Indicative Announcement on Change in Actual Controller and Persons Acting in Concert's Equity Reaching an Integer Multiple of 5%
March 11, 2026
Announcement on Voluntary Disclosure of the Controlling Company Implanet’s 3D-Printed Lumbar Interbody Fusion System Receiving U.S. FDA 510(k) Clearance
March 4, 2026
Announcement on Preliminary Earnings Estimate for 2025
February 26, 2026
Announcement on Outward Investment
February 11, 2026
Announcement on the Listing and Circulation of Partial Restricted Shares under the Share Issuance and Cash Payment for Asset Acquisition and Supporting Fundraising and Related Party Transactions
February 4, 2026
Announcement on Obtaining Government Subsidies
January 29, 2026
Preannouncement on Expected Increase in Performance for 2025
January 28, 2026
Announcement on Shareholding Reduction Plan for Actual Controller and Person Acting in Concert
January 12, 2026
Announcement on Voluntary Disclosure of Subsidiary’s Signing of the Cooperation Operation Agreement
December 2, 2025
Announcement on the Shareholding Change of the Actual Controllers and Persons Acting in Concert Crossing the 1% Threshold and the Shareholding Reduction by the Actual Controllers and Persons Acting in Concert
December 1, 2025
Announcement on Resolutions of the 5th Extraordinary General Meeting in 2025
November 7, 2025
Report for Q3 2025
October 27, 2025
Announcement on Renewing Engagement of Accounting Firm
October 22, 2025
Announcement on Resolutions of the 4th Meeting of the 4th Board of Directors
September 26, 2025
Indicative Announcement on Pricing for Shareholders' Inquiry-based Transfer
September 23, 2025
Shareholders' Inquiry Transfer Plan
September 22, 2025
Announcement on Resolutions of the 4th Extraordinary General Meeting in 2025
September 12, 2025
Announcement on Correction of 2025 Semi-annual Report
September 8, 2025
Announcement on Adding a Special Account for Raised Funds and Signing a Tripartite Supervision Agreement on Special Account Deposit of Raised Funds
September 5, 2025
Announcement on Obtaining Medical Device Registration Certificate for Bone Filling Capsule
August 28, 2025
Announcement on Resolutions of the 3rd Meeting of the 4th Board of Directors
August 25, 2025
Announcement on Shareholding Reduction Plan by Person Acting in Concert with Actual Controller
August 13, 2025
Announcement on Shareholding Reduction Result of Directors and Senior Executives
July 25, 2025
Announcement on Voluntary Disclosure of the Obtaining of Medical Device Registration Certificate for the JAZZ Spinal Fixation Connector System
July 15, 2025
Announcement on Implementation of Dividend Distribution for 2024
July 10, 2025
Announcement on Completing Term Change and Election of Board of Directors and Appointing Senior Management Members and Securities Affairs Representative
July 4, 2025
Announcement on Equity Change of Director-cum-Senior Officer Exceeding 1% and Progress in Share Reduction
June 19, 2025
Notice on Convening the 3rd Extraordinary General Meeting in 2025
June 17, 2025